Through our integrated platform and proprietary, AI-powered technology we can

MAKE

Precision Oncology the Standard of Care for everyone

PREDICT

Optimal treatment options

ACCELERATE

Therapeutic and clinical innovation

OPTIMIZE

Physician resources

News

More News
More News

The Perthera Platform

The Perthera AI Precision Oncology Platform uses multi-omic testing results and past patient history to match cancer patients with ranked therapy options, and accelerates clinical and therapeutic innovation through our AI-enhanced RWE pipeline.

Learn More
Perthera Report® Ranked therapies Optimize treatment, supercharge clinical oncology workflows, and shorten time to decision. Virtual Molecular Tumor Board A unique asynchronous collaboration between physicians and technology to provide efficient and accessible expertise. CROs Accelerate R&D Access Perthera’s data pipeline with oncographic queries, and match patients to clinical trials. RWE Data pipeline Leverage RWE, built on multiomic inputs and enhanced by our proprietary AI-powered analysis engine. Perthera Engine
Perthera Platform

Cancer care takes on new dimensions

Clinical Oncologists face unprecedented pressures and competition for resources.

AI-powered Solutions

$42,000+

The average cost of medical care and drugs in the year following cancer diagnosis

75%

Of chemotherapy could be ineffective, and compounds non-cancer complications

2.1M

New cancer cases in the US in 2024

7,450

Approximate active clinical trials involving Oncology

Cancer care takes on new dimensions

Clinical Oncologists face unprecedented pressures and competition for resources.

AI-powered Solutions

Decision support is physician support

Generational advancements in AI, data, and computation technologies mean that clinical oncology is no longer for the human physician alone.

Read our latest press releases

2.4x

Improvement in progression-free survival with Perthera

20%

Of Perthera patients enrolled in clinical trials (6x the national average)

600

Hospitals/Clinics use the Perthera Platform

10%

Of Medical Oncologists in the US have ordered a Perthera Report®

AI-enabled precision, speed and scale

Precision oncology and speed to decision, for everyone, at every point of care.

Contact Us

Our Partners

Accru
AstraZeneca
Baylor Scott & White Charles A. Sammons Cancer Center
Caris Life Sciences
Cedars-Sinai
Champlain Valley Physicians Hospital
City of Hope
Foundation Medicine
Guardian Research Network
Inova Fairfax Hospital
John Hopkins Medicine
Lung Cancer Alliance*
Massivebio
Mayo Clinic
MD Anderson Cancer Center
Merck
Natera
Neo Genomics
New York Presbyterian
Novartis
Pfizer
Puma
Seattle Cancer Care Alliance
Sharp Memorial Hospital
Theralink
Thomas Jefferson University Hospital*
UVA Health
Virginia Mason Franciscan Health